Oncology Clinical Trials in Tucson, AZ

As of August 2026, 95 paid clinical trials are recruiting for Oncology in Tucson, Arizona. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

95 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Tucson, AZ.

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for Metastatic Clear Cell Renal Cell Carcinoma

Sites in Tucson, Gilbert +338 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020

Apply to this trial

Arizona Cancer Center Biospecimen Repository

for Cancer

1 location in Tucson

Sponsor: University of Arizona

Sex: All·Age: 18+

Code: NCT00896935·Recruiting·Listed May 2009

Apply to this trial

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for Grade 3b Follicular Lymphoma

Sites in Tucson +98 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05890352·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

4-aminopyridine Treatment for Nerve Injury

for Nerve Injury

1 location in Tucson

Sponsor: John Elfar

Sex: Male·Age: 45 - 75

Code: NCT03701581·Phase 2, Phase 3·Recruiting·Listed Oct 2018

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

Sites in Tucson, Phoenix +54 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting·Listed Feb 2013

Apply to this trial

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

for Breast Cancer

1 location in Tucson

Sponsor: University of Arizona

Sex: Female·Age: 40+·Accepts healthy volunteers

Code: NCT03954431·Recruiting·Listed May 2019

Apply to this trial

The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

for Breast Cancer Female

1 location in Tucson

Sponsor: University of Arizona

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05676255·Phase 2·Recruiting·Listed Jan 2023

Apply to this trial

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

for Brain Metastases

1 location in Tucson

Sponsor: University of Arizona

Sex: All·Age: 18 - 99

Code: NCT06055790·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

for Alopecia

Sites in Tucson +1 more location

Sponsor: Cooler Heads Care Inc.

Sex: Female·Age: 21+

Code: NCT05484973·Recruiting·Listed Aug 2022

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Tucson, Phoenix +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Tucson +66 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Tucson, Scottsdale +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 99

Code: NCT06467357·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Tucson +64 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Tucson +48 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for Hepatocellular Carcinoma

Drug: Rilvegostomig

Sites in Tucson, Phoenix +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06921785·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Conditions in Oncology (Tucson, AZ)

Breast cancer· 16 Solid tumor· 15 Non-small cell lung cancer (NSCLC)· 12 Acute myeloid leukemia (AML)· 8 Colorectal cancer· 5 Chronic lymphocytic leukemia (CLL)· 5 Diffuse large B-cell lymphoma (DLBCL)· 5 Cancer (any)· 5 Metastatic breast cancer· 4 Pancreatic cancer· 4 Prostate cancer· 4 Metastatic prostate cancer· 4 Non-Hodgkin lymphoma· 4 Lung cancer· 3 Kidney cancer· 3 Ovarian cancer· 3 Endometrial cancer· 3 Fallopian tube cancer· 3 Leukemia (other)· 3 Myelodysplastic syndromes (MDS)· 3 Hematologic malignancy· 3 Head and neck cancer· 3 HER2-negative breast cancer· 2 Esophageal cancer· 2 Liver cancer· 2 Biliary tract cancer· 2 Bladder cancer· 2 Brain metastases· 2 Multiple myeloma· 2 Follicular lymphoma· 2 Mantle cell lymphoma· 2 Small lymphocytic lymphoma· 2 Melanoma· 2 Osteosarcoma· 2 Triple-negative breast cancer· 1 Cervical cancer· 1 Uterine cancer· 1 Glioblastoma· 1 Acute lymphoblastic leukemia· 1 Myelofibrosis· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Marginal zone lymphoma· 1 Neuroblastoma· 1 Mesothelioma· 1